A proposal to create an opioid study committee and crack down on scammers who prey on addicts has sailed through the Georgia Senate.
Dr. Brenda Fitzgerald’s complex financial investments presented conflicts that made it difficult to do her job, according to a statement from the Department of Health and Human Services, which oversees the CDC
It remains clear that the increasingly polarized immigration debate is having a chilling effect on Hispanic participation in health care programs, particularly during the enrollment season that ended in December.
U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.
The first trial date has been set for a lawsuit by a state against pharmaceutical companies over the opioid epidemic.
President Donald Trump’s pick for health secretary said he’s wary of a broad government role in negotiating prescription drug prices, arguing that it may lead to reduced access for patients.
Veterans Affairs Commissioner David Shulkin says officials estimate that about 20 veterans a day take their own lives.
A U.S. judge in New Mexico has dismissed more than two dozen complaints against the maker of American Spirit cigarettes but is allowing others to move forward over a line of tobacco touted as natural.
A deadline burst of sign-ups after a tumultuous year for the Obama health law has revealed continued demand for the program’s subsidized individual health plans. But the Affordable Care Act’s troubles aren’t over.
Health leaders say they are alarmed about a report that officials at the nation’s top public health agency are being told not to use certain words or phrases in official budget documents, including “fetus,” ″transgender” and “science-based.”